OUTLOOK THERAPEUTICS Company Leadership
| OTLK Stock | USD 2.23 0.04 1.83% |
OUTLOOK THERAPEUTICS's insiders are aggressively buying. The analysis of the overall insider sentiment regarding OUTLOOK THERAPEUTICS INC suggests that most insiders are extremely bullish. OUTLOOK THERAPEUTICS employs about 24 people. The company is managed by 13 executives with a total tenure of roughly 30 years, averaging almost 2.0 years of service per executive, having 1.85 employees per reported executive.
| Ralph Thurman Chairman Executive Chairman of the Board |
| Elizabeth Yamashita President Vice President - Regulatory Affairs |
OUTLOOK THERAPEUTICS's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2024-09-26 | Lawrence A Kenyon | Acquired 5000 @ 5.69 | View | ||
| 2024-03-28 | Yezan Munther Haddadin | Acquired 1882 @ 11.82 | View |
Monitoring OUTLOOK THERAPEUTICS's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
OUTLOOK |
OUTLOOK THERAPEUTICS's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with OUTLOOK THERAPEUTICS's future performance. Based on our forecasts, it is anticipated that OUTLOOK will maintain a workforce of about 80 employees by February 2025.OUTLOOK THERAPEUTICS Management Team Effectiveness
The company has return on total asset (ROA) of (0.8369) % which means that it has lost $0.8369 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0365) %, meaning that it created substantial loss on money invested by shareholders. OUTLOOK THERAPEUTICS's management efficiency ratios could be used to measure how well OUTLOOK THERAPEUTICS manages its routine affairs as well as how well it operates its assets and liabilities. At this time, OUTLOOK THERAPEUTICS's Return On Capital Employed is quite stable compared to the past year. Return On Equity is expected to rise to 1.25 this year, although the value of Return On Tangible Assets will most likely fall to (3.16). At this time, OUTLOOK THERAPEUTICS's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 34.8 T this year, although the value of Non Current Liabilities Other will most likely fall to about 52.5 K.Common Stock Shares Outstanding is expected to rise to about 22.4 B this year, although the value of Net Loss will most likely fall to (62.4 M).
OUTLOOK THERAPEUTICS Workforce Comparison
OUTLOOK THERAPEUTICS INC is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,807. OUTLOOK THERAPEUTICS claims roughly 24.0 in number of employees contributing just under 2% to equities under Health Care industry.
OUTLOOK THERAPEUTICS Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OUTLOOK THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on OUTLOOK THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, OUTLOOK THERAPEUTICS insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2023-06-01 | 3.0 | 3 | 1 | 641,429 | 520,000 |
| 2023-03-01 | 2.0 | 8 | 4 | 328,520 | 431,155 |
| 2022-06-01 | 5.0 | 5 | 1 | 83,977,512 | 27,982,529 |
| 2022-03-01 | 22.0 | 22 | 1 | 3,932,536 | 2,500,000 |
| 2021-03-01 | 2.5 | 10 | 4 | 12,519,738 | 145,127 |
| 2020-06-01 | 3.0 | 3 | 1 | 75,000 | 0.00 |
| 2020-03-01 | 3.0 | 15 | 5 | 43,848,660 | 4,794,076 |
| 2019-12-01 | 12.0 | 12 | 1 | 3,468,836 | 3,636,364 |
| 2019-09-01 | 1.0 | 2 | 2 | 451,620 | 2,700 |
| 2019-06-01 | 4.0 | 4 | 1 | 9,456,127 | 3,636,364 |
| 2018-09-01 | 4.5 | 9 | 2 | 628,377 | 68,835 |
| 2018-06-01 | 2.0 | 8 | 4 | 64,995,203 | 216,536 |
| 2018-03-01 | 0.6667 | 2 | 3 | 31,367 | 114,677 |
| 2017-12-01 | 2.1667 | 13 | 6 | 17,173,920 | 154,126 |
| 2017-03-01 | 1.0 | 1 | 1 | 12,036 | 12,036 |
| 2016-12-01 | 2.5 | 20 | 8 | 891,272 | 464,533 |
| 2016-06-01 | 0.2727 | 6 | 22 | 146,499 | 855.00 |
OUTLOOK THERAPEUTICS Notable Stakeholders
An OUTLOOK THERAPEUTICS stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OUTLOOK THERAPEUTICS often face trade-offs trying to please all of them. OUTLOOK THERAPEUTICS's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OUTLOOK THERAPEUTICS's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Russell III | CEO President | Profile | |
| Ralph Thurman | Executive Chairman of the Board | Profile | |
| Elizabeth Yamashita | Vice President - Regulatory Affairs | Profile | |
| Jennifer Kissner | Senior Vice President Clinical Development | Profile | |
| Alicia Tozier | Marketing President | Profile | |
| Lawrence CPA | CFO, EVP | Profile | |
| Terry Dagnon | Chief Officer | Profile | |
| Balu Balasubramanian | Advisor | Profile | |
| Jeffrey Evanson | Chief Officer | Profile | |
| Jedd Comiskey | Senior Europe | Profile | |
| Joel Prieve | VP Operations | Profile | |
| Rick Gregory | Director Communications | Profile | |
| Surendra MD | Senior Affairs | Profile |
About OUTLOOK THERAPEUTICS Management Performance
The success or failure of an entity such as OUTLOOK THERAPEUTICS INC often depends on how effective the management is. OUTLOOK THERAPEUTICS management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OUTLOOK management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OUTLOOK management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.01) | (3.16) | |
| Return On Capital Employed | 6.01 | 6.31 | |
| Return On Assets | (3.01) | (3.16) | |
| Return On Equity | 1.19 | 1.25 |
OUTLOOK THERAPEUTICS Workforce Analysis
Traditionally, organizations such as OUTLOOK THERAPEUTICS use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OUTLOOK THERAPEUTICS within its industry.OUTLOOK THERAPEUTICS Manpower Efficiency
Return on OUTLOOK THERAPEUTICS Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 3.1T | |
| Net Loss Per Executive | 5.8T |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.06) | Revenue Per Share | Quarterly Revenue Growth 6.583 | Return On Assets | Return On Equity |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.